Safety and Tolerability of Repeat Courses of IM Alefacept
Public ClinicalTrials.gov record NCT00233662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Repeat Courses of Intramuscular Administration of Alefacept (LFA-3/IgG1 Fusion Protein) in Patients With Chronic Plaque Psoriasis
Study identification
- NCT ID
- NCT00233662
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Alefacept Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2002
- Primary completion
- Not listed
- Completion
- Nov 30, 2005
- Last update posted
- Aug 22, 2023
2002 – 2005
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Irvine | Irvine | California | 92697 | — |
| University of California, San Francisco | San Francisco | California | 94118 | — |
| Clinical Research Specialists, Inc. | Santa Monica | California | 90404 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06430-6231 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Central Dermatology | St Louis | Missouri | 63117 | — |
| University of Medicine and Dentistry Robert Wood Jonhson Medical School | New Brunswick | New Jersey | 08903-0019 | — |
| New York University School of Medicine | New York | New York | 10016 | — |
| The Mount Sinai School of Medicine | New York | New York | 10029-6547 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| University Hospitals of Cleveland | Cleveland | Ohio | 44106-5028 | — |
| Rivergate Dermatology | Goodlettsville | Tennessee | 37072-2301 | — |
| Baylor Dermatology Research Center | Dallas | Texas | 75246 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| University of Utah School of Medicine | Salt Lake City | Utah | 84132 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23507 | — |
| Dermatology Associates | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00233662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 22, 2023 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00233662 live on ClinicalTrials.gov.